Susquehanna International Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $592K | Buy |
|
|||||
|
2025
Q1 | $316K | Buy |
|
|||||
|
2024
Q4 | $173K | Sell |
|
|||||
|
2024
Q3 | $178K | Sell |
|
|||||
|
2024
Q2 | $224K | Sell |
|
|||||
|
2024
Q1 | $749K | Buy |
|
|||||
|
2023
Q4 | $163K | Sell |
|
|||||
|
2023
Q3 | $654K | Sell |
|
|||||
|
2023
Q2 | $1.14M | Buy |
|
|||||
|
2023
Q1 | $621K | Buy |
|
|||||
|
2022
Q4 | $157K | Buy |
|
|||||
|
2022
Q3 | $121K | Sell |
|
|||||
|
2022
Q2 | $344K | Buy |
|
|||||
|
2022
Q1 | $308K | Buy |
|
|||||
|
2021
Q4 | $98K | Sell |
|
|||||
|
2021
Q3 | $2.75M | Buy |
|
|||||
|
2021
Q2 | $333K | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|